Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

作者： Ariadna Carol Illa1,2, Sarah Baumgarten1, Dennis Danielsen1, Karin Larsen3, Torben Elm1, Peter B. Johansen4, Tom Knudsen5, Brian Lauritzen1, Mikael Tranholm6, Carsten D. Ley1 1Global Drug Discovery,Novo Nordisk A/S, 2Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences,University of Copenhagen, 3Department of Biomedical Sciences, Faculty of Health and Medical Sciences,University of Copenhagen, 4Independent consultant, 5Catalyst Biosciences, 6Værløse Dyreklinik

简介：

Overview

The refined tail vein transection (TVT) bleeding model provides a sensitive in vivo method for assessing hemophilic bleeding in anesthetized mice. This optimized model utilizes blood loss and bleeding time as key endpoints, refining previous models and eliminating death as an endpoint.

Key Study Components

Research Area

• Hemophilia
• Coagulation disorders
• In vivo pharmacological assessment

Background

• Importance of reliable bleeding models for pharmacological studies
• Use of anesthesia to minimize animal distress
• Need for models that accurately measure blood coagulation

Methods Used

• Tail vein transection bleeding model
• Hemophilia A mice as biological system
• Measurement of bleeding time and blood loss as endpoints

Main Results

• Significant reduction in blood loss observed with recombinant factor VIII treatment
• Bleeding time normalized in treated groups
• Strong correlation between blood loss and bleeding time across experiments

Conclusions

• The study confirms the effectiveness of the refined TVT model for evaluating hemostatic therapies
• Demonstrates the relevance of optimized animal models in preclinical hemophilia research

Frequently Asked Questions